- Previous Close
12.99 - Open
13.30 - Bid --
- Ask --
- Day's Range
12.07 - 13.30 - 52 Week Range
1.44 - 36.00 - Volume
34,849 - Avg. Volume
81,610 - Market Cap (intraday)
37.684M - Beta (5Y Monthly) 3.85
- PE Ratio (TTM)
-- - EPS (TTM)
-2.02 - Earnings Date Jun 4, 2025 - Jun 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
www.exicuretx.comRecent News: XCUR
View More
Performance Overview: XCUR
Trailing total returns as of 3/18/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XCUR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XCUR
View MoreValuation Measures
Market Cap
39.48M
Enterprise Value
45.26M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
47.40
Price/Book (mrq)
25.55
Enterprise Value/Revenue
90.52
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-26.52%
Return on Equity (ttm)
-132.62%
Revenue (ttm)
500k
Net Income Avi to Common (ttm)
-4.01M
Diluted EPS (ttm)
-2.02
Balance Sheet and Cash Flow
Total Cash (mrq)
343k
Total Debt/Equity (mrq)
396.63%
Levered Free Cash Flow (ttm)
-1.04M
Research Analysis: XCUR
View MoreCompany Insights: XCUR
XCUR does not have Company Insights